{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:15:27Z","timestamp":1768828527696,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.contraception.2007.10.009","type":"journal-article","created":{"date-parts":[[2008,1,24]],"date-time":"2008-01-24T15:57:31Z","timestamp":1201190251000},"page":"171-176","source":"Crossref","is-referenced-by-count":14,"title":["Novel ethinyl estradiol-beta-cyclodextrin clathrate formulation does not influence the relative bioavailability of ethinyl estradiol or coadministered drospirenone"],"prefix":"10.1016","volume":"77","author":[{"given":"Hartmut","family":"Blode","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf","family":"Sch\u00fcrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Benda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2007.10.009_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.contraception.2004.05.013","article-title":"Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone","volume":"70","author":"Bachmann","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.10.009_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00044011-200626030-00004","article-title":"Efficacy and safety of a low-dose 21-day combined oral contraceptive containing ethinylestradiol 20 \u03bcg and drospirenone 3 mg","volume":"26","author":"Cibula","year":"2006","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.contraception.2007.10.009_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jn\/123.4.676","article-title":"Fate of beta-cyclodextrin in the human intestine","volume":"123","author":"Flourie","year":"1993","journal-title":"J Nutr"},{"key":"10.1016\/j.contraception.2007.10.009_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1021\/js960213f","article-title":"Pharmaceutical applications of cyclodextrins: III. Toxicological issues and safety evaluation","volume":"86","author":"Irie","year":"1997","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.contraception.2007.10.009_bib5","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1021\/cr970025p","article-title":"Cyclodextrins drug carrier systems","volume":"98","author":"Uekama","year":"1998","journal-title":"Chem Rev"},{"key":"10.1016\/j.contraception.2007.10.009_bib6","first-page":"1","article-title":"Cyclodextrins in drug carrier systems","volume":"3","author":"Uekama","year":"1987","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.contraception.2007.10.009_bib7","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1021\/js960075u","article-title":"Pharmaceutical applications of cyclodextrins: 2. In vivo drug delivery","volume":"85","author":"Rajewski","year":"1996","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.contraception.2007.10.009_bib8","first-page":"139","article-title":"Cyclodextrins: application in different routes of drug administration","volume":"55","author":"Shimpi","year":"2005","journal-title":"Acta Pharm"},{"key":"10.1016\/j.contraception.2007.10.009_bib9","doi-asserted-by":"crossref","first-page":"E329","DOI":"10.1208\/pt060243","article-title":"Cyclodextrins in drug delivery: an updated review","volume":"6","author":"Challa","year":"2005","journal-title":"AAPS PharmSciTech"},{"issue":"4 Suppl","key":"10.1016\/j.contraception.2007.10.009_bib10","first-page":"11S","article-title":"Drospirenone 3 mg\/ethinylestradiol 20 mcg combined oral contraceptive in the treatment of acne vulgaris: lesion count, ISGA","volume":"109","author":"Maloney","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"4 Suppl","key":"10.1016\/j.contraception.2007.10.009_bib11","first-page":"102S","article-title":"Drospirenone 3 mg\/ethinylestradiol 20 mcg in the treatment of acne vulgaris: patient self-assessment","volume":"109","author":"Maloney","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.10.009_bib12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.10.009_bib13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2007.10.009_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2007.10.009_bib15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.steroids.2003.08.008","article-title":"Conception and pharmacodynamic profile of drospirenone","volume":"68","author":"Elger","year":"2003","journal-title":"Steroids"},{"issue":"Suppl 3","key":"10.1016\/j.contraception.2007.10.009_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13697130500330382","article-title":"Pharmacology of different progestogens: the special case of drospirenone","volume":"8","author":"Sitruk-Ware","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.contraception.2007.10.009_bib17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/13625180008500407","article-title":"A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers","volume":"5","author":"Blode","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2007.10.009_bib18","series-title":"Handbook of experimental pharmacology","first-page":"281","article-title":"Pharmacokinetics of exogenous natural and synthetic estrogens and antiestrogens","author":"Kuhnz","year":"1999"},{"key":"10.1016\/j.contraception.2007.10.009_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/ejc.6.3.167.171","article-title":"Transfer of drospirenone to breast milk after a single oral administration of 3 mg drospirenone+30 microg ethinylestradiol to healthy lactating women","volume":"6","author":"Blode","year":"2001","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2007.10.009_bib20","first-page":"18","article-title":"Pharmacokinetics of drospirenone","volume":"7","author":"Blode","year":"2002","journal-title":"Gynaecol Forum"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782407005069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782407005069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T05:40:32Z","timestamp":1557207632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782407005069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0010782407005069"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2007.10.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}